Structure Therapeutics Inc. American Depositary Shares (GPCR · NASDAQ)
GPCR · MARKET VIEW
Market view · as of Jun 22, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-0.35
vs $-0.35 est · in line
52-wk position
36.5%
-52.5% vs 52w high · +20.7% 1mo
Price (last ~year)
Structure Therapeutics (GPCR) is a clinical-stage biopharmaceutical company with a $3.16 billion market cap, reporting no revenue and a $76.2 million net loss for the quarter ended March 31, 2026. The company maintains $316.2 million in cash against $5.8 million in total debt. Shares closed at $44.51, up 20.7% over the past month, following recent shareholder meetings and director option grants.
Valuation
- Market cap
- $3.16B
- P/B
- 2.19
- EV/EBITDA
- -13.46
- Beta
- -1.423
- Analyst target
- $104.59
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -15.0%
- ROA
- -11.6%
Price movement
- Last
- $44.51
- 1-month
- +20.7%
- 3-month
- -5.4%
- RSI (14)
- 68
- vs SMA200
- -7.7%
- 52-wk position
- 36.5% -52.5% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $0 | $-89.6M | $-76.2M | $-74.8M |
| 2025-12-31 | $0 | $24.0M | $33.0M | $33.6M |
| 2025-09-30 | $0 | $-73.8M | $-65.7M | $-65.3M |
| 2025-06-30 | $0 | $-70.5M | $-61.7M | $-61.2M |
Recent news
- Neutral Shareholders Approve Directors, Auditors at 2026 Meeting · 2026-06-19
- Neutral Structure Therapeutics (GPCR) grants 39,453-share option award to director · 2026-06-19
- Neutral Structure Therapeutics (GPCR) director receives 39,453 share options at $15 · 2026-06-19
- Neutral Director at Structure Therapeutics (NASDAQ: GPCR) gets 39,453 options · 2026-06-18
- Neutral [Form 4] Structure Therapeutics Inc. Insider Trading Activity · 2026-06-18
- Neutral Structure Therapeutics (GPCR) director receives 39,453 share options at $15 · 2026-06-18
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)